Skip to content
Ichilov Medical Center
Oncology

Treatment of Angioimmunoblastic T-Cell Lymphoma in Israel

The Ichilov Clinic employs top-notch oncologists and hematologists with a global reputation and experience in combating various hematological oncological pathologies. Here, the most effective treatment for angioimmunoblastic T-cell lymphoma in Israel. Doctors regularly participate in scientific research, conduct clinical trials of new methods and approaches.

>80%
of patients choose an online consultation with an Israeli expert even before arriving at the clinic
>30%
of patients received innovative treatment unavailable in local clinics
1726
patients underwent comprehensive examination and treatment under the guidance of Israeli doctors while staying at home

Treatment of Angioimmunoblastic T-Cell Lymphoma in IsraelGreat attention is paid at Ichilov to therapeutic individualization. Multidisciplinary teams consisting of oncologists, hematologists, radiologists, surgeons, and other specialists study the problem comprehensively and adapt the treatment plan for each patient based on the genetic and molecular characteristics of their pathology. This significantly increases effectiveness and reduces the risks of side effects. The medical center is equipped with the latest diagnostic equipment, applying advanced methods of immunotherapy, targeted therapy, and personalized medicine.

About the Disease

Angioimmunoblastic T-cell lymphoma (AILT) is a type of non-Hodgkin lymphoma that belongs to the group of peripheral T-cell lymphomas. The disease represents an aggressive lymphoproliferative process affecting the immune system. It is a tumour of immature malignant immune T-cells with abnormal blood vessels. The pathology is characterized by the proliferation of vascular endothelium, in which the paracortical area is replaced by tissue with an excessive content of T-lymphocytes and plasma cells.

The disease primarily affects the lymphatic system, including lymph nodes and, to a lesser extent, the spleen and liver. Due to the ability of T-lymphocytes to spread throughout the body, the pathology can affect the skin and other organs.

The exact causes of AILT development have not yet been established. Genetic and environmental factors are suspected to influence it; however, specific triggers or risks for the development of this disease remain unknown.

Symptoms of the disease include:

  • enlargement of lymph nodes, usually painless;
  • fever, weight loss, night sweats (the 'lymphoma triad' symptoms);
  • skin rashes;
  • enlargement of the spleen (splenomegaly) and liver (hepatomegaly);
  • general weakness, fatigue.

Autoimmune phenomena, such as hemolytic anemia or immune thrombocytopenia, are sometimes observed.

Treatment Methods for the Disease

Treatment of angioimmunoblastic T-cell lymphoma (AILT) involves the use of several approaches aimed at controlling disease progression, optimizing prognosis, and improving quality of life. Therapy options are selected based on the stage of the disease and the overall health of the patient.

Chemotherapy

Is the primary method of treating AILT, based on medications that affect rapidly dividing cells. Procedures aim to localize and destroy tumours and prevent disease spread. The selection of chemotherapy protocols depends on the individual characteristics of the disease course.

In the treatment of AILT, combined regimens of several drugs are used to enhance the overall effectiveness of treatment. During the chemotherapy course, regular monitoring of the patient's condition is conducted, allowing for prompt adjustments to treatment if necessary.

Targeted Therapy

A modern method developed to combat cancer cells at the molecular level. The peculiarity of this method is that treatment targets specific molecules and biochemical pathways that play a key role in the development and spread of malignant tumours. Targeted drugs are synthesized to accurately and effectively block or inhibit these targets, stopping the growth and preventing the survival of cancer cells.

The advantage of targeted therapy is not only in its targeted action but also in reducing the number and severity of side effects compared to traditional chemotherapy. Targeted drugs are developed considering the characteristics of cancer cells, allowing them to act precisely on the tumour while minimizing damage to healthy tissues.

Immunotherapy

Immunotherapy is one of the promising treatment methods aimed at activating the body's own immune system. The main goal of immunotherapy is to enhance the body's ability to recognize and destroy defective cells, making it a powerful tool in the arsenal against cancer. This approach can be used as a standalone method or in combination with other therapeutic strategies.

Most often, the treatment of angioimmunoblastic T-cell lymphoma (AILT) involves:

  • monoclonal antibodies – drugs targeting specific molecules on the surface of cancer cells, helping the immune system recognize and destroy these cells;
  • immune checkpoint inhibitors – drugs that block proteins that help cancer cells evade attack from the immune system, thereby enhancing the immune system's ability to fight cancer.

Stem Cell Transplantation

This procedure is considered one of the methods of comprehensive treatment, especially in situations where the disease recurs or there are high risks of relapse. Most often, transplantation is resorted to in order to use the maximum possible doses of chemotherapy drugs. Intensive treatment affects not only malignant but also healthy cells, necessitating the restoration of bone marrow functions. Doctors transplant healthy stem cells to restore the bone marrow, resume its functions, and produce healthy blood cells. The choice of transplantation method is individual and is considered taking into account many factors, including the stage of the disease, the overall health of the patient, and previous treatment experience.

  • Stem Cell Treatment
  • Chemotherapy

Diagnostic Methods for the Disease

The diagnosis of angioimmunoblastic T-cell lymphoma (AILT) requires a comprehensive approach. The Ichilov Clinic conducts a series of tests that allow for accurate confirmation or exclusion of lymphoma as the cause of symptoms. There are several subtypes of AITL, so standard diagnostics may include additional tests.

First Day

The doctor collects complaints and analyzes symptoms, studies the medical history, family history, and chronic diseases. A physical examination is conducted.

Second Day

  • Laboratory blood tests
  • Histopathological examination of lymph node biopsy
  • Imaging methods
  • Immunological study and search for specific markers
  • Bone marrow examination

Third Day

A multidisciplinary group, including an oncologist-hematologist, radiologist, histopathologist, and other specialists, studies the diagnostic results and determines the subtype of lymphoma. An accurate diagnosis allows for the selection of optimal treatment options for AILT. Therapy is always individualized and depends on many factors, including the stage of the disease, the patient's age, the presence of comorbidities, and the overall condition of the body.

  • Computed Tomography
  • Magnetic Resonance Imaging (MRI)
  • Diagnosis – PET CT

How Much Does Treatment Cost

Treatment at the Ichilov Clinic is developed individually, taking into account the results of genetic and molecular characteristics and the specifics of the disease course for each patient. The price is influenced by the number and type of procedures, for example, the need for immunological or targeted drugs.

Call the number listed on the website and ask any questions you may have. You can contact a medical consultant through the feedback form or online chat. The specialist will explain how much a standard treatment plan costs and the cost of individual procedures. They will tell you how to apply for a consultation and treatment, where to find information about doctors specializing in AILT treatment, and view ratings and reviews of departments.

Advantages of Treatment at the Ichilov Clinic

  1. Highly qualified specialists
  2. Individualized approach to treatment
  3. Multidisciplinary teams applying advanced technologies
  4. Access to innovative treatment methods
  5. Attention to patient comfort and quality of life

Israel is one of the world leaders in the treatment of oncological and hematological diseases, including angioimmunoblastic T-cell lymphoma. You can order a consultation with leading doctors at the Ichilov Clinic directly from home. To do this, you need to send the available conclusions and test results to the clinic's email address. Within a few days, you will be able to personally talk to a doctor via video call through Zoom or Skype, hear their opinion on your situation, and receive recommendations for further actions.

Get a treatment plan

Attach your discharge notes and imaging — Ichilov physicians will review and propose an optimal plan.

    Request a callback

    A coordinator will call back shortly and answer your questions.